Two DNA dependent DNA polymerases, DNA polymerase az and 1, are found in the cell nucleus and are involved in the synthesis of nuclear DNA (Hubscher, 1983) . DNA polymerase a is associated with proliferating tissues (Lynch et al., 1976) and tumours (DePhilip et al., 1977) , and is elevated during the late G, to mid S phase of the cell cycle, whereas the activity of DNA polymerase P remains unchanged (Chiu & Baril, 1975; Barr et al., 1975) . In vivo, the activity of DNA polymerase a has been correlated with cellular proliferation in a variety of steroid hormone target tissues including the rat ventral prostate gland (Rennie et al., 1975) and the rat uterus (Harris & Gorski, 1978) . DNA polymerase is tightly bound to the nucleus whereas DNA polymerase a is lightly bound and extracted under aqueous conditions (Foster & Gurney, 1976; Edwards et al., 1980) .
We have assessed breast tumour proliferation by measuring the activity of DNA (Lowry et al., 1951) .
Assay of DNA polymerase a activity DNA polymerase ax activity was determined as has been described previously (Edwards et al., 1980) using the incorporation of 3H-thymidine triphosphate (TTP) into an acid insoluble product with activated calf thymus DNA as a template primer (Aposhian & Kornberg, 1962) . In brief, 100 1l of tumour cytosol was added to 300gld containing 50mM Tris (pH7.4), 2.5mM dithiothreitol, 10mM MgCl2, 2 mM adenosine triphosphate, 0.2 mM deoxyadenosine triphosphate, deoxycytosine triphosphate and deoxyguanosine triphosphate, 80 tiM TTP, 1 I[Ci 3H-TTP and 250 Lg activated calf thymus DNA. After one hour the reaction was stopped by adding 22 ml 10% trichloroacetic acid (TCA) containing 1% sodium pyrophosphate. The acid insoluble product was collected on Whatman membrane filters (0.45itm diameter pore size) and then washed with a further 20 ml 5% TCA containing 1% sodium pyrophosphate. The filters were counted with 10ml of scintillation cocktail (Packard filter count). Samples were assayed in duplicate, and blank tubes (reaction stopped at time zero) were subtracted from the sample tubes. The coefficient of variation between duplicate assay tubes was 8%.
Under these conditions enzyme activity was linear with time for up to 2 hours and linear with protein concentration (1-5mg of protein ml-').
The (Nicholson et al., 1979 
Discussion
We have observed a significantly lower specific activity of DNA polymerase a in benign breast tumours compared with untreated malignant breast tumours suggesting that cellular proliferation in benign tumours was reduced. Some benign tumours were quiescent with no detectable DNA polymerase a activity while the DNA polymerase a activity in other benign tumours overlapped with that of some tumours in the malignant tumour group. Other techniques of assessing cellular proliferation have also shown a lower rate of proliferation in benign than in malignant breast tumours (Kute et al., 1981; Sincock, 1986 there may be no statistically significant change in mean DNA polymerase a activity before therapy compared with after, individual patients may show large changes. Clinical response rates to different endocrine therapies such 4-OH A and MPA are typically 30-40% (Harmsen & Porsius, 1988) .
A 4-OH A is thought to exert its antiproliferative action by causing a reduction in oestrogen production. Competitive inhibition of aromatase activity in human placental microsomes and tumour regression of hormone dependent carcinogen induced rat tumours following 4-OH A has been demonstrated (Brodie et al., 1983) . In postmenopausal women a single injection of 4-OH A (500 mg i.m.) suppressed serum oestradiol to an average of 36% of the base line after 4-7 days (Dowsett et al., 1987) .
High dose MPA (>500 mg day-') has been used with some success in the treatment of breast cancer (Izuo et al., 1981) and with other therapies (Ghilchik et al., 1987) . In vitro MPA has been shown to have an antiproliferative action on breast cancer cell growth and this was accompanied by a reduction in DNA polymerase a activity (Purohit et al., 1990) . The growth inhibitory action of MPA is thought to be mediated through the progestogen receptor (Horwitz et al., 1985) , but interactions of MPA with other steroid receptors have been reported (Teulings et al., 1980; Poulin et al., 1989) .
We found no significant correlation between oestrogen receptor binding and DNA polymerase a activity in untreated malignant tumours. A negative correlation between malignant breast tumour cell proliferation and oestrogen receptor binding has been reported (Meyer et al., 1986) but the correlation was of a low order. We did observe a significantly higher activity of DNA polymerase a activity in oestrogen receptor negative than oestrogen receptor positive malignant breast tumours. A higher rate of breast tumour proliferation, assessed by flow cytometry, has been found in oestrogen receptor negative than oestrogen receptor positive tumours (Kute et al., 1981) . No significant relationship between tumour size and DNA polymerase a was found in our study, however, a weak positive correlation between breast tumour size and tumour cell proliferation has been observed (Meyer et al., 1986) .
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